跳至主要内容
临床试验/NCT02274207
NCT02274207Unknown4 期

Phase IV Study of Antibacterial Effect on Silver Dressing of NPWT

Severance Hospital2 个研究点 分布在 1 个国家目标入组 74 人开始时间: 2014年12月最近更新:
适应症

试验速览

阶段
4 期
入组人数
74
试验地点
2
主要终点
Days to patient discharge

研究概览

简要总结

The purpose of this study is to test therapeutic benefits of silver dressing compared with non-silver dressing in NPWT(Negative pressure wound therapy). Silver dressing may antibacterial effect on infected diabetes mellitus foot.

详细描述

Investigator will recruit sixty patients. Participant will be randomly assigned to one of two groups. One is using silver dressing group in NPWT, another is using non-silver dressing group in NPWT. Participant will visit in screening day, NPWT apply day and F/u day for 4 months. Investigators will conduct to check the wound base, Lab, wound culture.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
20 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • The patient above 20 years and has type I, II of diabetes mellitus foot ulcer
  • Infected ulcer has one of below.
  • clinically infection symptom in ulcer area : warmth, erythema, tenderness/swelling
  • induration, purulent discharge etc.
  • Confirmed case of bacteria in wound culture.
  • Conformed case of abnormal range of erythrocyte sedimentation rate (ESR)/C-reactive protein(CRP) level in lab.
  • Has to be applied NPWT because suture is impossible in ulcer area.
  • The patient voluntary agreed to this protocol.
  • In the opinion of investigator, It is suitable to participate in this study.

排除标准

  • Infection in bone so patient need amputation
  • Female with childbearing, lactating or not agree to prevent pregnancy.
  • Has Sepsis, Osteomyelitis
  • Has Connective tissue disease of disturbance of healing of wound Ex) Rheumarthritis,systemic lupus erythematosus(SEL), myalgia.
  • The patient to diagnosis of Sickle sell disease or Charcot's joint.
  • The patient stability treated chronic wasting disease.
  • Malignant tumor or history of malignant disease. (Not diagnosis of complete recovery.)
  • The patient treated chemotherapy, radiation therapy, immune-suppressants therapy,adrenocortical hormones therapy.
  • Although necrosis tissue is removed, the target ulcer did not heal because of gangrenous, necrosis tissue or purulent pyorrhea.
  • Has ulcer with cardiac arrhythmia thrombus, venous insufficiency, diabetic necrobiosis lipoidic.
  • In case of using prohibited concomitant medications during study.
  • a. Oral system steroid b. Immune-suppressive drug c. Unfractionated heparin infusion d. improper drugs in the opinion of investigator.
  • Hypersensitivity with applicators. (NPWT, Silver)
  • The patient participated in other clinical trials within 30 days
  • In the opinion of investigator, the patient is not suitable to participate in this study.

结局指标

主要结局

Days to patient discharge

时间窗: up to 4 weeks

-Examine the days from applied medical device to discharge.

次要结局

  • Number of surgical debridement after NPWT(up to 8 weeks)
  • Rate of adverse event(up to 4 months (if adverse event appeared, Investigator follow until the disappearance of the symptom)
  • Complete infection clear rate in wound culture results(up to 4 months)
  • Days to infection clearance in wound culture results(4 months (at least once a week for 4 weeks / After dischage, every participant visit day(for 3 months)))
  • Wound closure rate(up to 4 months)
  • Lab - deviation of level(up to 4 months)
  • Days to complete wound closure(4 months (at least once a week for 4 weeks / After dischage, every participant visit day(for 3 months)))
  • Days of NPWT application period(up to 8 weeks)
  • Elevation of wound evaluations grade(4 months (at least once a week for 4 weeks / After dischage, every participant visit day(for 3 months)))

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Woojin Choi

Orthopedics

Severance Hospital

研究点 (2)

Loading locations...

相似试验

Comparative Study of Antibacterial Effect on Silver... | 临床试验